Literature DB >> 15049648

Enantiodivergent preparation of optically active oxindoles having a stereogenic quaternary carbon center at the C3 position via the lipase-catalyzed desymmetrization protocol: effective use of 2-furoates for either enzymatic esterification or hydrolysis.

Shuji Akai1, Toshiaki Tsujino, Emi Akiyama, Kouichi Tanimoto, Tadaatsu Naka, Yasuyuki Kita.   

Abstract

Both enantiomers of oxindoles 2a-h, having a stereogenic quaternary carbon center at the C3 position and a different N-protective group, were readily prepared by the lipase-catalyzed desymmetrization protocol. Thus, the transesterification of the prochiral diols 3a-h with 1-ethoxyvinyl 2-furoate 5 was catalyzed by Candida rugosa lipase to give (R)-(+)-2a-h (68-99% ee), in which the use of a mixed solvent, (i)Pr(2)O (diisopropyl ether)-THF, was crucial. The same lipase also effected the enantioselective hydrolysis of the difuroates 4a-h in a mixture of (i)Pr(2)O, THF, and H(2)O to provide the enantiomers (S)-(-)-2a-h (82-99% ee). The products 2 obtained by both methods were stable against racemization. These enzymatic desymmetrization reactions were also applicable for other typical symmetrical difuroates 12b and 15b to provide the racemization-resistant products 13b and 16b.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15049648     DOI: 10.1021/jo035749h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  4'-Amino-2,2''-dioxo-2,2'',3,3''-tetra-hydro-1H-indole-3-spiro-1'-cyclo-pent-3'-ene-2'-spiro-3''-1H-indole-3',5',5'-tricarbonitrile dihydrate.

Authors:  D Gayathri; D Velmurugan; G Shanthi; P T Perumal; K Ravikumar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-23

2.  Methyl 4-(4-bromo-anilino)-2',5-dioxo-5H-spiro-[furan-2,3'-indoline]-3-carboxyl-ate.

Authors:  Rajeswari Gangadharan; Selvarangam E Kiruthika; K Sethusankar; P T Perumal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.